Society for Translational Oncology

Home
United States
Durham, NC
Society for Translational Oncology

Directions Website

Our mission is to promote high-quality, equitable healthcare through innovative education and collaborative global efforts.

STO advances global oncology and patient care by bridging scientific discovery and clinical application, promoting equitable healthcare, and harmonizing cancer trials and regulatory standards to ensure swift access to life-saving treatments worldwide. Society for Translational Oncology: A Global Mission
The Society for Translational Oncology (STO), a 501(c)(3) not-for-profit organization, is dedicated to advancing global oncology and improving patient care by bridging the gap between scientific discovery and clinical application. Committed to diversity, inclusivity, and equity, STO empowers healthcare professionals with the knowledge and tools to implement cutting-edge cancer therapies and improve patient outcomes worldwide. Through strategic guidance and global alliances, we work to harmonize cancer clinical trials and regulatory standards, ensuring that life-saving treatments are speedily accessible to all patients with cancer. STO Continuing Medical Education Mission
STO is committed to providing impactful education to oncology physicians, with the goal of improving the quality and safety of care for patients with cancer. This mission will be fulfilled by offering relevant and effective continuing medical education programs, focusing on:
Knowledge and strategies for implementation of critical new developments in cancer treatment, screening, and prevention
The translational gap between research, discovery and delivery of care to the patient, providing content that is evidence-based and within the discipline of clinical medicine
Educational activities that are relevant and impact the practice of physicians within an oncology team in collaboration with nurses, pharmacists and other oncology healthcare professionals

10/26/2026

You’ve read the AI answer. It sounds convincing. Maybe even reassuring. But is it right? That is where the real conversation begins.

In this episode of STO’s Voices in Oncology, Amy DePue and Aimee Faso talk with Dr. David McSwain about AI, healthcare, and the people trying to make sense of both.

They get into the questions you might be asking, too:
🤔 What happens when patients bring AI-generated advice to an appointment?
🩺 Where does clinical judgment come in?
💬 Can technology leave more room for listening—not less?

You don’t need to be an AI expert to follow this conversation. Just curious about what comes next.

🎧 Press play: https://bit.ly/4Buct52

How can artificial intelligence improve healthcare without compromising safety, equity, or the patient-provider relationship? Dr. David McSwain, system chief medical informatics officer at UNC Health…

10/21/2026

We talk about screening. We talk about early detection. But we also need to talk about what happens after a breast cancer diagnosis.
Waiting for results. Managing side effects. Wondering whether a concern is worth bringing up. Trying to understand what comes next.

This Breast Cancer Awareness Month, read STO’s latest blog on the questions patients face and the conversations that can help them feel less alone.

Read the blog: https://bit.ly/4ia4dOy

You have cancer.” Now what? From agonizing waits to questions patients hesitate to ask, discover the conversations that bring clarity, confidence, and support after diagnosis.

10/16/2026

AI only knows what a person shares in the prompt. It may not know their full diagnosis, other health conditions, medications, test results, or treatment goals.

In cancer care, those details matter.

STO explores why patients deserve information that supports, not replaces, conversations with their clinical team: https://bit.ly/4BgiFh4

AI can sound confident, empathetic, and authoritative, even when critical clinical context is missing. Learn how fluency can mask gaps in judgment, context, and individualized care.

10/13/2026

You can talk about your cancer treatment. Can you talk about what it’s doing to your s*x life?

Menopausal symptoms, vaginal dryness, discomfort during s*x, changes in desire, and concerns about body image can all affect life during breast cancer treatment. Yet these topics can be difficult to raise, even with the people best equipped to help.

Aimee Faso and Amy DePue address these often-unasked questions in the latest Voices in Oncology and offer an important reminder: you don't have to suffer silently, and you shouldn't stop treatment because of side effects without first talking with your care team.

🎧 Listen: https://bit.ly/4ihLgLd

Breast cancer treatment doesn’t end when the initial treatment does. Some patients continue therapy for years while navigating changes to their bodies, hormones, relationships, and s*x lives.

10/07/2026

You’ve just been told you have cancer. What happens next?

The first few days can bring fear, uncertainty, a flood of questions, and very little sense of what comes next.

In this Voices in Oncology episode, Aimee Faso and Amy DePue talk about those first 30 days after diagnosis and why giving patients a roadmap early can help make an overwhelming experience more manageable.

🎧 Listen: https://bit.ly/4yEPPVQ

Hosts Aimee Faso and Amy DePue unpack the intense first month after a cancer diagnosis, from shock and staging to specialist visits, treatment planning, practical barriers, and the essential role of…

10/01/2026

AI can sound clear, caring, and confident. That does not mean it has the full clinical context needed to guide a patient safely.

STO’s latest article examines the risk of mistaking fluency for expertise and why oncology conversations still require individualized clinical judgment.

Read more: https://bit.ly/4jwZTLB

09/24/2026

“Get screened” isn’t the right message for every gynecologic cancer.

Cervical cancer has established prevention and screening strategies. For several other gynecologic cancers, awareness depends more on recognizing symptoms and understanding personal risk.

That distinction matters.

Read the latest STO blog: https://bit.ly/4Av3zUd

Five gynecologic cancers, five different stories, and five different ways to recognize risk, spot warning signs, pursue screening, and take action.

09/18/2026

What does medication adherence actually look like in practice? It's not just "did you take your pill". It's understanding how a patient is taking it, and creating space for them to tell you when something's not working. 💊

In our newest episode, Dr. Benyam Muluneh shares real examples from oncology care and talks about the misconceptions many clinicians hold about their patients' adherence.

🎧 Catch Part 2 of Voices in Oncology from STO https://bit.ly/4y5pf80

09/11/2026

Your patient missed a dose. Now what?

The most important question may not be “Why didn't you take it?”
It may be: “What got in the way?”

Dr. Benyam Muluneh explores what oncology teams can uncover when they look beyond the missed pill and why the answer can change the conversation. 🎧 Listen to Part 1 of our latest podcast. https://bit.ly/46fgKei

09/11/2026

“Gynecologic cancer” covers five very different diseases.

Cervical. Uterine. Ovarian. Vulvar. Vaginal.

Different risks. Different warning signs. Different ways to detect them. Different actions.

This Gynecologic Cancer Awareness Month, know what makes each one different.

Read: https://bit.ly/4ho0u0E

Address

Durham, NC

Website

https://sto-online.org/

Alerts

Be the first to know and let us send you an email when Society for Translational Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.